TerrAscend Corp.
TSX:TSND.TODrug Manufacturers - Specialty & Generic
-$0.02 today
- Market cap
- $193.65M
- Beta
- 2.04
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$0.26
Volume 0.26M
Average 0.31M
TSND.TO Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
TerrAscend Corp.TSX: TSND.TO
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $4.52M fell 17.6% year over year, ahead of the -28.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 4.0% from the prior quarter. Over 3 fiscal years it compounded at -9.8% a year.
Context
- Depreciation & amortization amounted to 6.6% of revenue in FY2025, down 0.9 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -17.6% holds above the trailing-twelve-month pace of -28.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 17.51M USD
- Year-over-year change
- -23.8%
- 4-year CAGR
- +6.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 17.51M | -23.8% |
| FY2024 | 2024-12-31 | 22.99M | -25.0% |
| FY2023 | 2023-12-31 | 30.64M | +28.3% |
| FY2022 | 2022-12-31 | 23.87M | +75.1% |
| FY2021 | 2021-12-31 | 13.63M | — |
Depreciation & Amortization vs competitors
How TSND.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -28.6% is the 9th highest of 10, against a peer median of -0.8%.
- Depreciation & amortization amounts to 6.2% of revenue for TSND.TO, versus a peer median of 7.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$40.12M CAD | -6.9% | -23.0% | 12.9% | |
| LTM Mar 2026 | $21.99M USD | -0.8% | -13.6% | 39.4% | |
| LTM Mar 2026 | CA$19.76M CAD | +37.8% | — | 7.2% | |
| LTM Mar 2026 | $16.25M USD | -28.6% | -9.8% | 6.2% | |
| LTM Mar 2026 | CA$14.19M CAD | -37.1% | -31.2% | 4.5% | |
| LTM Mar 2026 | $13.77M USD | -26.6% | -9.0% | 4.5% | |
| LTM Mar 2026 | CA$11.86M CAD | +14.9% | -19.0% | 7.5% | |
| LTM Mar 2026 | $7.22M USD | +30.0% | +94.1% | 14.2% | |
| LTM Mar 2026 | $263.19K USD | +45.4% | +6.5% | — | |
| LTM Mar 2026 | $101.93K USD | -1.0% | — | 0.2% | |
| Peer median (excluding TSND.TO) | — | -0.8% | -13.6% | 7.3% | |
Competitors are the stored peer set for TSND.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (21.82M) | 22.61M | (27.63M) | (72.67M) | (24.49M) |
| Depreciation & Amortization | 13.63M | 23.87M | 30.64M | 22.99M | 17.51M |
| Deferred Income Tax | (1.81M) | (46.02M) | (18.92M) | (8.75M) | (532K) |
| Stock-Based Compensation | 14.93M | 12.18M | 7.71M | 9.71M | 5.01M |
| Change in Working Capital | (45.17M) | 37.81K | 35.67M | 28.84M | 23.24M |
| Accounts Receivables | (4.02M) | 3.73M | (12.5M) | (2.95M) | 1.67M |
| Inventory | (23.19M) | 881.27K | (7M) | 4.17M | 6.05M |
| Accounts Payables | 3.53M | (15.78M) | 869.2K | (5.29M) | (4.59M) |
| Other Working Capital | (21.49M) | 11.2M | 52.07M | 32.91M | 20.11M |
| Other Non-Cash Items | (4.62K) | (38.8M) | (2.42K) | 57.84M | 1.34M |
| Operating Cash Flow | (38.43M) | (33.38M) | 27.47M | 37.95M | 22.07M |
| Capital Expenditures | (50.39M) | (54.61M) | (9.43M) | (10.55M) | (8.76M) |
| Acquisitions (Net) | (53.55M) | 19.77M | (16.79M) | (250K) | (8.68M) |
| Purchases of Investments | (62.65M) | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 34.17M | 7.27M | 5.44M | (2.64M) | 3.16M |
| Investing Cash Flow | (132.42M) | (27.58M) | (16.22M) | (12.25M) | (15.03M) |
| Debt Repayment | (3.67M) | 54.4K | (27.76M) | (17.18M) | 8.36M |
| Common Stock Issued | 200.83M | 23.62M | 20.82M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (215K) | (417.18K) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (14.96M) | (19.95M) | (5.56M) | (7.32M) | (3.69M) |
| Financing Cash Flow | 182.2M | 3.72M | (12.5M) | (24.72M) | 4.26M |
| Effect of Forex Changes | 2.45M | (2.9M) | (168K) | 653K | (2.11M) |
| Net Change in Cash | 20.42M | (52.88M) | (1.42M) | 1.64M | 9.19M |
| Free Cash Flow | (88.82M) | (88M) | 18.04M | 27.4M | 13.31M |
TerrAscend Corp.
TSX:TSND.TO
Intrinsic Alpha fair value
Locked
Current Price
$0.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.